Compounds and compositions for delivering active agents
3 Assignments
0 Petitions
Accused Products
Abstract
Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.
107 Citations
28 Claims
-
1. A compound selected from
and salts thereof.
-
2. A composition comprising:
-
(A) an active agent; and
(B) at least one compound selected from and salts thereof. - View Dependent Claims (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)
(A) the composition of claim 2; and
(B) (a) an excipient (b) a dilutent (c) a disintegrant, (d) a lubricant, (e) a plasticizer, (f) a colorant, (g) a dosing vehicle, or (h) any combination thereof.
-
-
15. The dosage unit form of claim 14, wherein the active agent is selected from the group consisting of a biologically active agent, a chemically active agent, and a combination thereof.
-
16. The dosage unit form of claim 15, wherein the biologically active agent comprises at least one protein, polypeptide, peptide, hormone, polysaccharide, mucopolysaccharide, carbohydrate, or lipid.
-
17. The dosage unit form of claim 16, wherein the biologically active agent is selected from the group consisting of:
growth hormones, human growth hormones (hGH), recombinant human growth hormones (rhGH), bovine growth hormones, porcine growth hormones, growth hormone releasing hormones, growth hormone releasing factor, interferons, α
-interferon, β
-interferon, γ
-interferon, interleukin-1, interleukin-2, insulin, porcine insulin, bovine insulin, human insulin, human recombinant insulin, insulin-like growth factor, insulin-like growth factor-1, heparin, unfractionated heparin, heparinoids, dermatans, chondroitins, low molecular weight heparin, very low molecular weight heparin, ultra low molecular weight heparin, calcitonin, salmon calcitonin, eel calcitonin, human calcitonin;
erythropoietin, atrial naturetic factor, antigens, monoclonal antibodies, somatostatin, protease inhibitors, adrenocorticotropin, gonadotropin releasing hormone, oxytocin, leutinizing-hormone-releasing-hormone, follicle stimulating hormone, glucocerebrosidase, thrombopoeitin, filgrastim. postaglandins, cyclosporin, vasopressin, cromolyn sodium, sodium chromoglycate, disodium chromoglycate, vancomycin, desferrioxamine, parathyroid hormone, fragments of PTH, antimicrobials, anti-fungal agents, vitamins;
analogs, fragments, mimetics and polyethylene glycol-modified derivatives of these compounds; and
any combination thereof.
-
18. The dosage unit form of claim 15, wherein the biologically active agent comprises insulin, heparin, calcitonin, parathyroid hormone, erythropoietin, human growth hormones or combinations thereof.
-
19. The dosage unit form of claim 15, wherein the active agent comprises recombinant human growth hormone.
-
20. The dosage unit form of claim 15, wherein the active agent comprises parathyroid hormone.
-
21. The dosage unit form of claim 15, wherein the active agent comprises insulin.
-
22. The dosage unit form of claim 15, wherein the active agent comprises heparin.
-
23. The dosage unit form of claim 15, wherein the active agent comprises calcitonin.
-
24. The dosage unit form of claim 15, wherein the active agent comprises interferon.
-
25. The dosage unit form of claim 15, wherein the dosage unit form comprises a dosing vehicle comprising a tablet, a capsule, a powder, or a liquid.
-
26. The dosage unit form of claim 15, wherein the dosing vehicle is liquid selected from the group consisting or water, 1,2-propane diol, ethanol, and any combination.
-
27. A method for administering a biologically-active agent to an animal in need of the agent, the method comprising administering orally to the animal the composition of claim 3.
Specification